Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q2 2018 Earnings

10MayConfirmed

Q3 2017

Q4 2017

Q1 2018

Q2 2018

-0.24

0.12

0.49

0.85

Details

Expected EPS

-0.23

Actual EPS

-0.19

Surprise EPS

0.04

Surprise Percent

+17.39%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.19 per share for Q2 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.